USPTO serial 79267857
ALLTAQ
Reviewed by CopyMark Law Group
Reg. 6110068Status 708Renewal
- Filing date
- Status date
- Registration date
- Jul 28, 2020
- Examiner
- EISNACH, MICHAEL PATRICK
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ALLTAQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel M. Gurfinkel
Daniel M. Gurfinkel Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific purposes and non-medical reagents, namely, enzymes and buffer solutions for scientific and medical research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, namely, nucleic acids; enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids for other than medical and veterinary purposes; chemical analysis kits comprising enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, namely, nucleic acids for laboratory or research use | ACTIVE | — |
| 005 | [ Diagnostic preparations for human medical purposes, namely, enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids for medical purposes ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Sep 14, 2026 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Sep 8, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 9, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jul 28, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 5, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 18, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 18, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 18, 2020 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 28, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 28, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 12, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 12, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 22, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 24, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 20, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 19, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 18, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 8, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 29, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 28, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 5, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 1, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 21, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 19, 2019 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |